Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

ASX:BSL
ASX:BSLMetals and Mining

Will BlueScope’s A$438m Special Dividend Change BlueScope Steel's (ASX:BSL) Capital Allocation Narrative

Earlier in January 2026, BlueScope Steel Limited announced it would return A$438 million in surplus cash to shareholders via an unfranked special dividend of A$1.00 per share, with shares trading ex-dividend from 20 January, a record date of 21 January and payment scheduled for 24 February. This one-off cash return highlights BlueScope’s current capital management priorities and raises questions about how the company balances reinvestment with shareholder distributions. We’ll now examine how...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Viatris Launches Inpefa In UAE As Valuation And Growth Draw Focus

Viatris (NasdaqGS:VTRS) has launched Inpefa, a dual SGLT1/2 inhibitor for heart failure, in the United Arab Emirates. This marks the company's first international commercial rollout of Inpefa. The launch introduces a first in class cardiovascular therapy to patients in the UAE. For you as an investor, this move highlights how Viatris is adding to its presence in branded treatments alongside its established portfolio. Cardiovascular care continues to be a major focus area for global...
NasdaqGS:LYTS
NasdaqGS:LYTSElectrical

LSI Industries (LYTS) Margin Dip To 4.3% Tests Bullish Earnings Growth Narrative

LSI Industries (LYTS) has just posted Q2 2026 results with revenue of US$147.0 million and basic EPS of US$0.20, alongside trailing twelve month revenue of US$591.8 million and EPS of US$0.84 that frame the latest quarter against a fuller year of operations. The company has seen quarterly revenue move from US$147.7 million and EPS of US$0.19 in Q2 2025 to US$147.0 million and EPS of US$0.20 in Q2 2026, with net income shifting from US$5.6 million to US$6.3 million over the same period, while...
NasdaqGS:DXPE
NasdaqGS:DXPETrade Distributors

Is It Time To Reassess DXP Enterprises (DXPE) After Recent Share Price Strength

If you are wondering whether DXP Enterprises' current share price lines up with its underlying value, you are not alone. This article walks through what the numbers actually say. With the stock at US$132.09 and recent returns of 9.4% over 7 days, 14.4% over 30 days, 22.6% year to date and 23.4% over 1 year, many investors are reassessing both the growth potential and the level of risk they are comfortable with. DXP Enterprises has also been in the news for its role as a distributor and...
TSXV:GMG
TSXV:GMGElectrical

Is Graphene Manufacturing Group (TSXV:GMG) Using Conference Spotlights to Recast Its Graphene Technology Moat?

Graphene Manufacturing Group Ltd recently presented at Emerging Growth Conference 89 on January 22, 2026, with Founder and CEO Craig Nicol addressing investors. This appearance gives the company a platform to outline its graphene technology roadmap directly to a broad audience of growth-focused investors. We will now examine how this high-profile conference presentation could influence Graphene Manufacturing Group’s investment narrative and future positioning. Explore 23 top quantum...
TSX:PRV.UN
TSX:PRV.UNIndustrial REITs

Global's Top Undervalued Small Caps With Insider Action In January 2026

As we enter January 2026, global markets are experiencing mixed performances with small-cap and value stocks gaining momentum over large-cap counterparts, as evidenced by the S&P MidCap 400 and Russell 2000 Indexes reaching all-time highs. Against this backdrop of economic indicators such as cooling core consumer prices and robust retail sales growth, identifying promising small-cap stocks becomes crucial for investors seeking potential opportunities in a dynamic market environment.
BMV:ALSEA *
BMV:ALSEA *Hospitality

3 Global Stocks Estimated To Be Up To 49.8% Below Intrinsic Value

As global markets navigate a complex landscape marked by mixed earnings reports, fluctuating consumer prices, and geopolitical developments, investors are increasingly focused on identifying opportunities within the current economic climate. Amidst these conditions, value stocks have shown resilience and potential for growth, making the search for undervalued stocks particularly relevant. In this context, understanding intrinsic value becomes crucial as it can help investors identify stocks...
SZSE:300344
SZSE:300344Electronic

Global's Top Penny Stocks To Watch In January 2026

As we enter January 2026, global markets are experiencing a mix of economic signals, with U.S. core consumer prices rising at their slowest pace since 2021 and small-cap stocks hitting new highs. Amidst these developments, investors are increasingly turning their attention to penny stocks—an investment area that remains relevant despite its somewhat outdated terminology. These smaller or newer companies can offer unique growth opportunities when backed by strong financials, making them...
SZSE:002993
SZSE:002993Tech

Undiscovered Gems in Global Markets to Watch This January 2026

As January 2026 unfolds, global markets are experiencing a mix of economic signals, with small-cap stocks in the U.S. reaching new highs amid a backdrop of cooling core consumer prices and mixed earnings reports from major corporations. In this dynamic environment, identifying stocks that offer potential value and growth opportunities can be particularly rewarding for investors seeking to capitalize on market trends.
ASX:VEA
ASX:VEAOil and Gas

Assessing Viva Energy Group’s Valuation After Leadership Transition And New Board Appointments

Leadership changes at Viva Energy Viva Energy Group (ASX:VEA) has announced a planned board transition, with long-serving Chair the Honourable Robert Hill AC retiring in March 2026 and current director Dr Sarah Ryan FTSE appointed as Chair elect. Dr Ryan, who joined the Viva Energy board in 2018, brings more than 30 years of global energy sector and investment management experience. Incoming Independent Non Executive Director Alistair Bell adds extensive commercial and financial leadership...
SEHK:2269
SEHK:2269Life Sciences

New UK MHRA Certifications and PatroLab Platform Might Change The Case For Investing In WuXi Biologics (Cayman) (SEHK:2269)

WuXi Biologics recently announced that its Wuxi Drug Product Facility 5 and Drug Product Packaging Center received UK MHRA GMP certifications for commercial ophthalmic biologic manufacturing, alongside the launch of its PatroLabTM digital twin platform for real-time bioprocess monitoring and control. Together, these developments highlight WuXi Biologics’ growing role as a globally compliant manufacturer that is integrating advanced digital technologies to enhance biologics quality and...
NYSE:EPAM
NYSE:EPAMIT

EPAM Systems Deepens Enterprise AI Push With Cursor And Google Cloud Agents

EPAM Systems (NYSE:EPAM) has entered into a partnership with Cursor to expand its enterprise generative AI capabilities. The company has introduced several new AI agents on Google Cloud Marketplace as part of this effort. These moves are aimed at supporting enterprise clients that are adopting generative AI solutions. EPAM Systems is leaning into AI driven services at a time when many enterprises are experimenting with generative tools and automation. The stock last closed at $219.05, with...
NasdaqGS:LECO
NasdaqGS:LECOMachinery

Lincoln Electric Quality Screen Win Puts Valuation And Debt In Focus

Lincoln Electric Holdings (NasdaqGS:LECO) was recently recognized for its financial health and competitive advantages after passing a respected quality investing screen. The screen highlights companies with resilient balance sheets, consistent execution, and durable business models. This recognition singles out Lincoln Electric’s long term positioning in welding, cutting, and joining solutions as especially robust. Lincoln Electric focuses on arc welding equipment, consumables, and...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

Is United Therapeutics (UTHR) Attractive After Recent Pullback And Strong Multi Year Gains?

If you are trying to work out whether United Therapeutics at about US$472 per share looks expensive or reasonable, you are in the right place. The stock has been flat over the last 7 days, with a 7.5% decline over the past month and a 5.0% decline year to date, set against a 26.9% return over 1 year, 78.7% over 3 years and 187.2% over 5 years. Recent coverage around United Therapeutics has focused on how the company is positioned within the pharmaceuticals and biotech space and how investors...
NYSE:SPXC
NYSE:SPXCMachinery

Is It Too Late To Consider SPX Technologies (SPXC) After A 5-Year 297% Rally?

If you are wondering whether SPX Technologies at around US$217 a share still offers value, you are not alone, and that is exactly what this article aims to unpack. The share price sits at US$217.13, with returns of 1.6% over the past week, 5.7% over the last 30 days, 6.8% year to date, 40.7% over 1 year, 202.2% over 3 years, and 297.1% over 5 years, which naturally raises questions about what is already priced in and what might come next. Recent attention on SPX Technologies has centered on...
ASX:COL
ASX:COLConsumer Retailing

A Look At Coles Group’s Valuation As Goldman Sachs Starts Coverage With A Neutral Rating

Coverage initiation puts Coles Group (ASX:COL) in focus Goldman Sachs has initiated coverage on Coles Group (ASX:COL) with a Neutral rating, citing regulatory risks from federal court proceedings on discounting practices and highlighting margin pressure from higher wage costs and increased scrutiny. See our latest analysis for Coles Group. Coles Group’s 1 year total shareholder return of 12.61% and 3 year total shareholder return of 33.89% sit against weaker recent momentum, with a 90 day...
NYSE:GPGI
NYSE:GPGITech

Is It Too Late To Consider CompoSecure (CMPO) After Its Recent Share Price Surge

If you are wondering whether CompoSecure's share price still reflects fair value after its recent run, this article will walk through what the current market price might be implying about the business. The stock last closed at US$25.15, with returns of 29.7% over the past 30 days, 34.7% year to date, 97.7% over the past year, and a very large gain over three years that is a little more than 4x. Recent coverage has highlighted CompoSecure's position in secure payment and authentication...
NYSE:CADE
NYSE:CADEBanks

Cadence Bank (CADE) Margin Slip To 28.6% Tests Bullish Growth Narrative

Cadence Bank (CADE) has put up a clean set of FY 2025 numbers, with fourth quarter revenue at US$500.4 million and EPS at US$0.76, while trailing twelve month revenue came in at US$1.9 billion and EPS at US$2.83. Over recent periods the bank has seen revenue move from US$435.7 million in Q4 2024 to US$500.4 million in Q4 2025, with quarterly EPS stepping from US$0.70 to US$0.76. This sets the stage for investors to focus on how consistently the bank converts that income into margins and long...
TSX:GURU
TSX:GURUBeverage

Guru Organic Energy (TSX:GURU) Posts Second Straight Profit Challenging Turnaround Skeptics

GURU Organic Energy (TSX:GURU) has wrapped up FY 2025 with fourth quarter revenue of C$10.1 million and basic EPS of roughly C$0.00, alongside net income of C$0.04 million as the company reports another year of results. The company has seen quarterly revenue range from C$6.5 million to C$10.4 million across FY 2025, while quarterly EPS moved between a loss of C$0.05 and a gain of C$0.04. This puts the latest print in the context of a year shaped by swings in profitability. With trailing...
NasdaqGS:FULT
NasdaqGS:FULTBanks

Fulton Financial (FULT) Net Interest Margin Holds 3.59% Challenging Bearish Profitability Narratives

Fulton Financial (FULT) has wrapped up FY 2025 with fourth quarter revenue of US$333.1 million and basic EPS of US$0.53, alongside net income of US$96.4 million, setting the tone for how the full year is being assessed. The company has seen trailing 12 month revenue move from US$1.15 billion at the end of 2024 to US$1.28 billion by the fourth quarter of 2025, with TTM EPS rising over the same window from US$1.59 to US$2.10. This frames the latest print against a steadily building earnings...